Materials scientists at the Saarland University and the Material Engineering Center Saarland have come up with a laser technology that allows for precise working on materials' surfaces. The laser beams generate 3-dimensional patterns and change the material's inner structure only at an extremely thin surface layer.
Astronomers have discovered bucket loads of buckyballs in space. They used NASA's Spitzer Space Telescope to find the little carbon spheres throughout our Milky Way galaxy - in the space between stars and around three dying stars. What's more, Spitzer detected buckyballs around a fourth dying star in a nearby galaxy in staggering quantities - the equivalent in mass to about 15 of our moons.
Scientists are reporting development of a new approach for dealing with offensive household and other odors - one that doesn't simply mask odors like today's room fresheners, but eliminates them at the source.
Today, Ecole Polytechnique Federale de Lausanne and IBM (NYSE: IBM) announced a major research initiative, with several leading academic and corporate research organizations across Europe, to address the alarming growth of energy consumption by electronic devices, ranging from mobile phones to laptops to televisions to supercomputers.
To protect art objects for generations to come, scientists from the A. James Clark School of Engineering at the University of Maryland, College Park, have teamed up with conservators from the Walters Art Museum in Baltimore, Md., to develop and test a new, high-tech way to protect silver art objects and artifacts, using coatings that are mere nanometers thick.
The use of nanotechnology in medicine holds the potential to essentially improve diagnosis, treatment and monitoring of disease activity. To foster research in this area, the European Commission is funding the collaborative project 'Development of Novel Nanotechnology Based Diagnosed Systems for Rheumatoid Arthritis and Osteoarthritis (NanoDiaRA)' within the 7th Framework Programme for Research.
Physicist Robert Huber, who leads a Junior Research Group at Ludwig-Maximilians-University (LMU) Munich, becomes the latest recipient of one of the coveted Starting Grants awarded by the European Research Council (ERC). The grant is worth 1.2 million Euros over a period of 5 years.
By combining an iron oxide nanoparticle, a tumor-targeting peptide, and a therapeutic nucleic acid into one construct, a team of investigators from the Massachusetts General Hospital and Harvard Medical School have created an agent that holds potential as targeted therapy for breast cancer.
Scientists have shown that the safety of gold nanoparticle-nucleic acid formulations depends significantly on how the nucleic acids and nanoparticles are linked to one another, a finding with important implications for those researchers developing such constructs.
Researchers at the Massachusetts Institute of Technology (MIT) and Brigham and Women's Hospital have developed a nanoparticle that can deliver precise doses of two or more drugs to prostate cancer cells. Such particles, say the researchers, could improve the effectiveness of chemotherapy while minimizing the side effects normally seen with these drugs.
Though targeted nanoparticle-based imaging agents and therapeutics for diagnosing and treating cancer are making their way to and through the clinical trials process, researchers still do not have a good understanding of how nanoparticles reach tumors and how they then bind to and enter the targeted tumor. To overcome that knowledge deficit, two teams of investigators, both part of the Alliance for Nanotechnology in Cancer have undertaken studies aiming to track nanoparticles as they move through living animals.